Login / Signup

Thiol-catalyzed formation of NO-ferroheme regulates intravascular NO signaling.

Anthony W DeMartinoLaxman PoudelMatthew R DentXiukai ChenQinzi XuBrendan S GladwinJesús TejeroSwati BasuElmira AlipourYiyang JiangJason J RoseMark T GladwinDaniel B Kim-Shapiro
Published in: Nature chemical biology (2023)
Nitric oxide (NO) is an endogenously produced signaling molecule that regulates blood flow and platelet activation. However, intracellular and intravascular diffusion of NO are limited by scavenging reactions with several hemoproteins, raising questions as to how free NO can signal in hemoprotein-rich environments. We explore the hypothesis that NO can be stabilized as a labile ferrous heme-nitrosyl complex (Fe 2+ -NO, NO-ferroheme). We observe a reaction between NO, labile ferric heme (Fe 3+ ) and reduced thiols to yield NO-ferroheme and a thiyl radical. This thiol-catalyzed reductive nitrosylation occurs when heme is solubilized in lipophilic environments such as red blood cell membranes or bound to serum albumin. The resulting NO-ferroheme resists oxidative inactivation, is soluble in cell membranes and is transported intravascularly by albumin to promote potent vasodilation. We therefore provide an alternative route for NO delivery from erythrocytes and blood via transfer of NO-ferroheme and activation of apo-soluble guanylyl cyclase.
Keyphrases
  • blood flow
  • red blood cell
  • nitric oxide
  • room temperature
  • coronary artery
  • cell therapy
  • metal organic framework
  • stem cells
  • nitric oxide synthase
  • reactive oxygen species
  • anti inflammatory
  • bone marrow